Clinical Trial Update: BRight Pharmacokinetic Study [NA]

View source ↗

Summary

Biotronik CRC Inc. reports that the BRight Pharmacokinetic Study has completed, relating to Peripheral Artery Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Snippet

Sponsor: Biotronik CRC Inc. | Conditions: Peripheral Artery Disease | NA | Status: COMPLETED